Risk factor modification is important in the prevention of aneurysmal subarachnoid hemorrhage (aSAH) in patients with unruptured aneurysms. Currently there are conflicting data on the role of antiplatelet and antithrombotic… Click to show full abstract
Risk factor modification is important in the prevention of aneurysmal subarachnoid hemorrhage (aSAH) in patients with unruptured aneurysms. Currently there are conflicting data on the role of antiplatelet and antithrombotic agents in the prevention of aSAH. Recent studies and meta-analyses show mixed findings, with some suggesting that the use of aspirin is associated with increased risk of aSAH1,2 and others demonstrating protective effects.3
               
Click one of the above tabs to view related content.